REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction

NCT06237309 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

89

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Heart Failure

Interventions

DRUG: REGN5381
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals